1 Context: Paradoxically, intramyocellular lipid (IMCL) accumulation has been linked to both 2 insulin-resistant and to insulin-sensitive (athletes) states. The composition of this lipid store is 3 unknown in these states. 4
Introduction 24
Following the demonstration that 1 H magnetic resonance spectroscopy ( 1 H MRS) can 25 noninvasively distinguish intramyocellular (IMCL) from extramyocellular (EMCL) lipids 26
(1,2), associations were reported between soleus IMCL accumulation and insulin resistance 27 (IR) independent of fat mass (3-5). Given that skeletal muscle accounts for a significant 28 amount of insulin-stimulated glucose disposal and thus represents the primary site for 29 postprandial glucose disposal (6), these findings were of considerable physiological interest. 30 Furthermore these data strongly supported the link between ectopic fat accumulation and 31 insulin resistance (7, 8) . Although it soon became clear that triglycerides themselves were 32 unlikely to be involved in causing insulin resistance, intramuscular triglyceride content does 33 appear to correlate with insulin resistance in some states (5, (9) (10) (11) (12) . One particularly striking 34 and surprising exception to this was reported in athletes, where histological studies suggested 35 that neutral lipid accumulation was a feature of skeletal muscle in insulin-sensitive trained 36 athletes (13, 14) , and this has led to the now widely cited notion of an 'athlete's paradox' (13) . 37
This concept is consistent with the idea that triglyceride itself is not involved in causing 38 insulin resistance and has prompted several efforts to identify the lipid intermediates 39 responsible for causing insulin resistance or preserving the insulin sensitivity of athletes. 40 Saturated fat has been implicated in the pathogenesis of metabolic disease (15,16) and we 41 have recently described and validated (using IMCL/EMCL simulated phantoms of known 42 composition) a 1 H MRS method that provides an in vivo compositional marker of IMCL that 43 primarily reflects the degree of saturation of the fatty acid chains within triglyceride (17) . 44
This marker, which we call the 'IMCL saturation index' (CH2:CH3), utilizes good quality 45 spectra acquired at 3T with short echo time and compares the CH2 resonance located at 1.3 46 ppm (which is influenced by both concentration and composition), with that of the CH3 47 4 resonance at 0.9 ppm which is independent of triglyceride composition: this is illustrated in 48 Figure 1. From this figure it can also be seen that using concentration of 'H' that resonate at 49 1.3 ppm (CH2) to represent the concentration of lipid without knowledge of the underlying 50 composition, as has been the practice in virtually all published 1 H MRS studies of IMCL so 51 far, confounds the contributions of both the concentration of lipid and its composition. This 52 has potential for significant error in the estimation of concentration: the composition could 53 contribute as much as 43% to the observed signal, which is equivalent to a 77 % theoretical 54 increase in signal if the pool was stearic acid instead of sunflower oil. We therefore use the 55 IMCL CH3 peak at 0.9 ppm to estimate the total concentration of IMCL, as this is 56 independent of the degree of saturation of the fatty acid chains within triglyceride (i.e. 57 composition). We call this the composition-independent IMCL concentration estimate, to 58 distinguish it from the conventional estimate using CH2. 59
Lipodystrophy is a rare cause of severe IR and is typically characterized by prominent ectopic 60 fat accumulation due both to the reduction in adipocyte lipid storage capacity and the 61 associated hyperphagia induced by leptin deficiency. In order to ascertain if intramyocellular 62 lipid composition is altered in lipodystrophic (LD) patients, and if such changes in lipid 63 composition might help to elucidate the 'athlete's paradox', we determined the compositional 64 saturation index (CH2:CH3 ratio) and composition-independent concentration (from CH3) of 65 IMCL in the soleus and tibialis anterior muscles of female insulin-resistant lipodystrophic 66 patients, as well as age-and gender-matched athletes and non-athlete controls. 67 68
Material and Methods

69
Participants 70
Sixteen female patients with lipodystrophy were identified as part of a long-standing study of 71 human IR syndromes, while age-and gender-matched controls (n=41) and athletes (n=14) 72 were recruited by advertisement. Soleus IMCL data from five of the patients were included in 73 a previously published study (18). Control and athlete exclusion criteria included smoking, 74 drug or alcohol addiction, any current or past medical disorder or medications that could 75 affect measurements including supplements such as creatine, and standard MR 76 contraindications. Controls were recruited who exercised less than 3 times per week for 1 77 hour each time, whilst the athletes were part of a running club, some at international level, 78 and all ran distances between 10 and 40 km regularly. The patient studies were approved by 79 the National Health Service Research Ethics Committee, the healthy volunteer studies by East 80 of England Cambridge Central Ethics Committee. Studies were conducted in accordance with 81 the Declaration of Helsinki and all participants provided written informed consent. 82
Protocol 83
Volunteers were instructed to follow normal dietary habits for 3 days prior to arrival at the 84 instructed to refrain from vigorous exercise for at least 24 hours prior to arrival at 08:00 when 90 fasting blood samples were taken before participants consumed a light breakfast, before 1 H 91 MRS at 09:30 followed by a maximal VO2max exercise test. Lipodystrophic patients also had 92 1 H MRS in the fed state but did not perform an exercise test. 93
HOMA-IR was calculated as fasting insulin (pmol/l)*fasting glucose (μU/ml) / 22.5. Body 94 composition was assessed by Dual-energy X-ray Absorptiometry (GE Lunar Prodigy encore 95 v12.5 or GE Lunar iDXA encore v16 (athletes). phosphocreatine at 3.0 ppm (Cr). As this resonance exhibits different lineshape characteristics 108 in the tibialis anterior and soleus muscles (23), comparable quantification between muscles 109 using a nominal concentration of muscle creatine is not valid; instead a scaling factor of Cr to 110 water signal for each muscle was established from a subset of participants who had non-111 water-suppressed datasets, yielding a calculated water signal (water-calc). Absolute 112 composition-independent IMCL concentrations in mmol/kg muscle wet weight (ww) were 113 calculated from the compositionally invariant CH3 IMCL resonance, with standard 114 assumptions regarding muscle water content, and correction for T2 relaxation effects, J 115 coupling and proton density as outlined in the supplementary information (24). The IMCL 116 saturation index (CH2:CH3) was calculated as IMCL CH2/CH3, and the IMCL saturation index 117 adjusted for quantity (CH2:CH3adj) = CH2 -(mCH3 + c), where m and c are the gradient and 118 intercept of the regression line through the control data points of CH2 vs CH3. Investigators 119 were blind to the insulin resistance status of the participants during 1 H MRS analysis. 120
Assessment of VO2max 121
Participants underwent continuous incremental exercise testing to 85% age-predicted 122 maximum heart rate (controls) or volitional exhaustion (athletes) on a treadmill (Trackmaster 123 TMX425, Med-electronics, MD). Oxygen consumption was measured using a spiro-124 ergometer (Medical Graphics UK Ltd and Breezesuit ® Gas exchange software). For the 125 control participants a standard incremental protocol was performed (25), while the athletes 126 undertook a protocol that began with a 10 min warm-up period at each participant's preferred 127 warm-up running speed, following which the test was initiated at 9 km/hr and increased 128 steadily (0.74 km.hr -1 .min -1 ), with a ramp at 5 minutes (increasing 0.5 % every 15s) until 129 exhaustion or a plateaux in VO2 was apparent. In controls VO2max was calculated by 130 extrapolating the submaximal heart rate -VO2 relationship to age-predicted maximum heart 131 rate (26). 132
Statistics 133
All statistics were performed in IBM SPSS Statistics 24 (IBM, Armonk, NY: IBM Corp.) 134 with significance set at P < 0.05. Normality was assessed by the Shapiro-Wilk test and non-135 normally distributed data were log-transformed prior to statistical testing. ANOVA with 136
Games-Howell post hoc analysis was used to compare means between groups, and Pearson's 137 correlation coefficient for analyzing associations. Due to the non-normality of LN(HOMA-138 IR), IMCL associations with HOMA-IR were assessed by Spearman's rank correlation 139 coefficient. Data are mean ± SEM. 140
Results
141
Participants 142
Of the insulin-resistant patients with lipodystrophy 13 had partial forms (8 patients with 143 FPLD2 due to LMNA mutations, 5 patients with FPLD3 due to PPARG mutations), and 3 144 generalized lipodystrophy (GLD, 2 patients with an acquired form -AGLD, and 1 due to 145 mutations in the PCYT1A gene (27)). EMCL was absent in the 2 patients with AGLD ( Figure  146 2), but those with partial forms had EMCL such that overall patients' EMCL was similar to 147 both controls and athletes (Table 1 ). The age-and gender-matched controls had a wide range 148 of BMI (19.6 -35.6 kg.m -2 ) and HOMA-IR (0.3 -4.9). As a group, insulin and HOMA-IR 149 were significantly higher in the LD patients and lower in the athletes (Table 1, Figure 3A ) 150 compared with controls, as expected. Fat mass and percentage body fat were similar between 151 LD patients and athletes, which were both lower compared to controls (Table 1, Figure 3B ). 152
Serum triglycerides were higher whilst high-density lipoprotein (HDL)-cholesterol 153 concentrations were lower in the LD patients (Table 1 ) compared to either controls or athletes. 154
H MRS analysis of intramyocellular TG concentration 155
In the soleus muscle intramyocellular TG concentrations derived from the IMCL CH3 peak 156 (0.9 ppm) (composition-independent IMCL concentrations) were not significantly increased 157 (p = 0.477) in the LD patients compared to controls, but were higher compared to the lean 158 athletes (p = 0.003) ( Figure 3C ). In the more glycolytic tibialis anterior muscle, composition-159 independent IMCL concentrations were similar in all three groups ( Figure 3D ). We also 160 observed linear inverse correlations of VO2max and IMCL concentration in the subset of 161 controls who underwent VO2max testing and athletes together ( Figures 3E & F) . Soleus IMCL 162 was significantly lower in the athletes compared to the controls (p = 0.004, Figure 3C ) and 163 this remained significant (p = 0.025) compared to a subset of the controls matched for 164 percentage body fat (body fat = 21.5±2.3 %, n = 10; vs athletes 21.1±1.8 %, n = 14; see 165 supplementary figure (24)). 166
The conventional estimate of IMCL concentration using the CH2 resonance uncorrected for 167 composition, CH2/water, showed similar trends to the composition-independent estimate 168 using the CH3 peak with the exception that the LD patients' soleus IMCL CH2 was 169 significantly increased compared to controls (Table 1) . This could be regarded as an artefact 170 of the effects of compositional differences, which we consider next. 171
H MRS analysis of intramyocellular lipid composition 172
IMCL had a significantly higher saturation index (CH2:CH3) in both muscles of the 173 lipodystrophic patients compared to controls (soleus p = 0.008, tibialis anterior p = 0.024), but 174 not athletes ( Figures 4A & B) . In the control group, smaller IMCL pools were associated with 175 a higher saturation index, as shown by the linear regression line (dotted line in Figures 4C &  176 D) having a gradient (ΔCH2/ΔCH3) < the mean CH2:CH3 (e.g. gradient soleus = 6.7 vs mean 177 CH2:CH3 = 8.8; gradient tibialis anterior = 4.2 vs mean CH2:CH3 = 6.0). This phenomenon 178 appeared to be independent of insulin sensitivity in the controls (Table 2: there was no 179 relation of HOMA-IR with IMCL concentration). To generate a pathophysiologically 180 meaningful measure of composition that is independent of IMCL quantity, the vertical (CH2) 181 deviation from this regression line was measured and taken as a marker of the saturation of 182 the pool that is adjusted for quantity, which we term the adjusted saturation index 183 (CH2:CH3adj). This adjusted compositional marker was significantly higher in lipodystrophic 184 patients compared to athletes (soleus p = 0.001, tibialis anterior p = 0.046) and also compared 185 to controls (soleus p = 0.003) with a tendency in the tibialis anterior which just falls short of 186 conventional statistical significance (p = 0.06) ( Figures 4E & F) . 187
Unlike the uncorrected measure of composition, this adjusted composition also had a 188 significant relation to VO2max ( Figures 4G & H) within the control subset alone, athletes alone 189 (soleus), and control and athletes combined (statistics are given in the figure legend), such 190 that fitter individuals had less saturated IMCL for the same absolute quantity of IMCL. 191
VO2max significantly correlated with HOMA-IR in the control subset (r = -0.59, p = 0.003, n = 192 23) and in controls and athletes together (r = -0.53, p = 0.001, n = 37). Table 2 and gender-matched athletes and healthy controls, and shown it to be significantly higher in 203 both muscles compared with controls, but not athletes. The finding that smaller IMCL pools 204 in the control group had a relatively higher saturation index than larger pools irrespective of 205 insulin sensitivity could possibly explain why the athletes studied here, who had small IMCL 206 pools, had a statistically similar composition to patients. This observed concentration -207 composition relation seems physiologically plausible given that more unsaturated and shorter-208 chain FA are preferentially mobilized (17). We hypothesize that a person may 'move' along a 209 line such as this while performing daily activities, and that a measurement of deviation from 210 this relationship may therefore be a more sensitive and specific measure of muscle metabolic 211 physiology or pathophysiology. To take this concentration-composition dependence into 212 consideration we adjusted the compositional saturation index for concentration (CH2:CH3adj), 213 and this marker was able to distinguish between athletes and lipodystrophic patients in both 214 muscles. The strong inverse relation of CH2:CH3adj with VO2max indicates that fitness is 215 associated with relatively lower saturation of IMCL, although overall athletes and controls 216 were not statistically different; this is similar to results from a biopsy study (28) that 217 demonstrated a comparable percentage saturated IMCL in controls and athletes. 218
By our measure of composition-independent IMCL (using the CH3 instead of the uncorrected 219 CH2 resonance) we found that the lipodystrophic patients' IMCL concentration was not 220 significantly higher in either muscle compared with age-, gender-and BMI-matched controls, 221 but was raised in the soleus relative to athletes. There are few reports of IMCL in 222 lipodystrophic patients, but our findings are in agreement with Peterson et al. (29) who, in 3 223 patients with generalized lipodystrophy (2 congenital, 1 acquired), found similar soleus IMCL 224 to 6 age-, BMI-and weight-matched controls. Calf IMCL was also lower in a case report of 225 acquired generalized lipodystrophy (30) compared to controls, whilst a study of 4 patients 226 with congenital generalized lipodystrophy suggested that IMCL was higher (31). Using the 227 CH2 resonance, as is conventional in previous literature, we found soleus IMCL 'content' to 228 be significantly higher in our LD patients compared with controls (Table 1) , demonstrating, 229 we argue, the influence of composition on measures of concentration. 230
The athlete's paradox 231
We found that the athletes' IMCL was significantly lower (soleus) or similar (tibialis anterior) 232 to controls. Although this appears to contradict well-known literature reports of an athlete's 233 paradox using both biopsy methods (13,28,32-34) and 1 H MRS (35,36), this finding is in 234 agreement with literature that reports no such paradox compared to old or young controls 235 (37), obese individuals (38), or in certain fibre types (14). It is known that athletes can have a 236 large depletion-repletion range of IMCL and it is possible that IMCL had not fully recovered 237 since the last training session (24 -48 hrs prior) as IMCL can still rise significantly after 238 these intervals (39). In fact, our results demonstrate an inverse relation of IMCL content and 239
VO2max which is consistent with a study by Boesch et al. (40) where a combination of daily 240 training at 60% VO2peak with a low fat (10-15 % fat) diet depleted IMCL levels in both the 241 vastus lateralis and tibialis anterior muscles to a consistent level that correlated with VO2peak, 242 suggesting our female elite athletes were nearly 'empty' of IMCL; we did not control for diet 243 in our study. 244
Relationship of whole-body insulin resistance to IMCL 245
Within the controls, only the compositional saturation index adjusted for quantity 246 (CH2:CH3adj) in soleus was significantly correlated with whole-body insulin resistance (Table  247 2). The inclusion of insulin-resistant patients increases the statistical significance of this 248 relation and also yields associations with other composition-influenced markers, but not 249 IMCL concentration in either muscle. In our study, the addition of athletes predictively 250 reduced the associations with composition as their pools were small and therefore had a 251 tendency for higher saturation index, but relations remain with measures that reflect large 252 saturated pools (i.e. CH2:CH3adj and CH2). These striking results suggest that the relative 253 composition and not concentration relates to early stage insulin resistance. 254
Limitations 255
Unlike previous 1 H MRS studies that have conventionally reported IMCL concentrations 256 using the predominant CH2 resonance whilst assuming a notional normal composition, here 257
we have utilized the smaller CH3 resonance which has the advantage of composition-258 independence and, with comprehensive prior knowledge constraints including line width 259 constraints relative to the CH2 resonance (22), fitted the IMCL CH3 resonance from the 260 overlapping EMCL/IMCL CH3 signals. Due to fibre orientation differences between the 261 soleus and tibialis anterior muscles the EMCL resonances are very slightly systematically 262 shifted between muscle groups. Despite this potential for a systematic difference in the 263 CH2:CH3 ratio between muscles, this ratio was still higher in the soleus compared to the 264 tibialis anterior muscle in both EMCL-deficient AGLD patients, consistent with findings in 265 our other participants in this study and a previous study (17) suggesting a compositional 266 difference between muscles. Our patients, who mainly had partial forms of lipodystrophy, had 267 overall similar quantities of EMCL to those of our controls and athletes which has helped in 268 reducing potential inter-group influence of this overlapping resonance. This, together with the 269 finding that the IMCL CH2:CH3 ratio had no relation to either EMCL CH2 or CH3 suggests a 270 lack of EMCL influence in our datasets; however, it is possible that in other insulin-resistant 271 cohorts large overlapping EMCL resonances may be a confounding factor. 272
Summary 273
Use of our recently validated and potentially widely applicable 1 H MRS approach to 274 determine both the IMCL composition and concentration independent of composition within 275 the soleus and tibialis anterior muscles of female individuals covering a wide range of insulin 276 sensitivities has revealed that the IMCL composition saturation index adjusted for quantity is 277 more strongly associated with whole-body insulin resistance than IMCL concentration alone. 
